Success Metrics

Completion Rate
0%(0/2)
Active Trials
1(33%)
Terminated
2(67%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(2)

Detailed Status

Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

active_not_recruiting133%
terminated267%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

A New Theory of Electrophysiological Mechanism of Atrial Fibrillation

NCT05845034
terminatednot_applicable

Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)

NCT01925885
terminatednot_applicable

Pulmonary Vein Ablation Versus Amiodarone in the Elderly

NCT01276093

Clinical Trials (3)

Showing 3 of 3 trials
NCT05845034Not Applicable

A New Theory of Electrophysiological Mechanism of Atrial Fibrillation

Active Not Recruiting
NCT01925885Not Applicable

Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)

Terminated
NCT01276093Not Applicable

Pulmonary Vein Ablation Versus Amiodarone in the Elderly

Terminated

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3